Real-World Effectiveness of Initial Disease-Modifying Therapies in Pediatric Multiple Sclerosis. Krysko KM, Graves JS, Rensel M, Weinstock-Guttman B, et al. Ann Neurol 2020;88:42-55.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Krysko KM, Graves JS, Rensel M, Weinstock-Guttman B, et al. Real-World Effectiveness of Initial Disease-Modifying Therapies in Pediatric Multiple Sclerosis. Ann Neurol 2020;88:42-55.
PMID: 32267005